Search Results - "DANE, FAYSAL"

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials by Saha, Poornima, Regan, Meredith M, Pagani, Olivia, Francis, Prudence A, Walley, Barbara A, Ribi, Karin, Bernhard, Jürg, Luo, Weixiu, Gómez, Henry L, Burstein, Harold J, Parmar, Vani, Torres, Roberto, Stewart, Josephine, Bellet, Meritxell, Perelló, Antonia, Dane, Faysal, Moreira, Antonio, Vorobiof, Daniel, Nottage, Michelle, Price, Karen N, Coates, Alan S, Goldhirsch, Aron, Gelber, Richard D, Colleoni, Marco, Fleming, Gini F

“…Purpose To describe benefits and toxicities of adjuvant endocrine therapies in women younger than 35 years with breast cancer (n = 582) enrolled in the…”
Get full text

Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment by Telli, Tugba Akin, Ozguven, Salih, Alan, Ozkan, Filizoglu, Nuh, Ozturk, Mehmet Akif, Sariyar, Nisanur, Isik, Selver, Arikan, Rukiye, Demircan, Nazim Can, Basoglu, Tugba, Cetin, Ilknur Alsan, Ones, Tunc, Ercelep, Ozlem, Dane, Faysal, Yumuk, Perran Fulden

“…Objective We aimed to evaluate whether baseline 68 Ga-PSMA PET/CT-derived whole-body volumetric parameters could be used as predictive biomarkers for survival…”
Get full text

The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study by Akdeniz, Nadiye, Kaplan, Muhammet Ali, Uncu, Doğan, İnanç, Mevlüde, Kaya, Serap, Dane, Faysal, Küçüköner, Mehmet, Demirci, Ayşe, Bilici, Mehmet, Durnalı, Ayşe Gök, Koral, Lokman, Şendur, Mehmet Ali Nahit, Erol, Cihan, Türkmen, Esma, Ölmez, Ömer Fatih, Açıkgöz, Özgür, Laçin, Şahin, Şahinli, Hayriye, Urakçı, Zuhat, Işıkdoğan, Abdurrahman

“…Purpose We aim to compare the efficiency and toxicity of three different 5-fluorouracil (5-FU) administration types in 5-FU, leucovorin, and oxaliplatin…”
Get full text

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment? by Alan, Ozkan, Akin Telli, Tugba, Aktas, Bilge, Koca, Sinan, Ökten, Ilker Nihat, Hasanov, Rahib, Basoglu, Tugba, Arikan, Rukiye, Demircan, Nazim Can, Ercelep, Ozlem, Kaya, Serap, Ugurlu, Mustafa Umit, Kaya, Handan, Akgul Babacan, Nalan, Dane, Faysal, Yumuk, Perran Fulden

“…Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a…”
Get full text

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study by Yalcin, Suayib, Dane, Faysal, Oksuzoglu, Berna, Ozdemir, Nuriye Yildirim, Isikdogan, Abdurrahman, Ozkan, Metin, Demirag, Guzin Gonullu, Coskun, Hasan Senol, Karabulut, Bulent, Evrensel, Turkkan, Ustaoglu, Mehmet Ali, Ozdemir, Feyyaz, Turna, Hande, Yavuzsen, Tugba, Aykan, Faruk, Sevinc, Alper, Akbulut, Hakan, Yuce, Deniz, Hayran, Mutlu, Kilickap, Saadettin

“…Combination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL)…”
Get full text

Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma by Basoglu, Tugba, Babacan, Nalan, Ozturk, Fatih, Arikan, Rukiye, Demircan, Nazim, Telli, Tugba, Ercelep, Ozlem, Dane, Faysal, Yumuk, Perran

“…Background: The Gustave Roussy immune score (GRIm score) is a laboratory index developed to predict survival in nonsmall cell lung cancer patients undergoing…”
Get full text

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study by Dane, Faysal, Ozgurdal, Kirhan, Yalçın, Şuayib, Benekli, Mustafa, Aykan, Nuri Faruk, Yücel, İdris, Özkan, Metin, Evrensel, Turkkan, Sevinç, Alper, Coskun, Hasan Şenol, Sanli, Ulus Ali, Kara, Ismail Oguz, Yumuk, Perran Fulden

“…ObjectivesRegorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase…”
Get full text

Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study by Koca, Sinan, Beşiroğlu, Mehmet, Özçelik, Melike, Karaca, Mustafa, Bilici, Mehmet, Hacıoğlu, Bekir, Doğu, Gamze G, Kaplan, Nihal B, Oruç, Zeynep, Aydın, Dinçer, Dane, Faysal

“…Purpose Soft tissue sarcomas are associated with a poor prognosis and low chemotherapeutic efficiency. Pazopanib is an orally available multi-tyrosine kinase…”
Get full text

The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers by AKIN TELLİ, Tuğba, AKGÜL BABACAN, Nalan, ALAN, Özkan, ÖZTÜRK, Mehmet Akif, HASANOV, Rahib, KOCA, Sinan, HALİL, Süleyman, TANRIKULU ŞİMŞEK, Eda, BAŞOĞLU, Tuğba, ERCELEP, Özlem, DANE, Faysal, YUMUK, Perran Fulden

“…Aim: DR-70 is a newly developed immunoassay that detects fibrin degradation products in blood. We aimed to evaluate ability of DR-70 in monitoring treatment…”
Get full text

A rare case of gastric cancer with bilateral breast metastasis during pregnancy by Basoglu, Tugba, Telli, Tugba Akin, Demircan, Nazim Can, Arikan, Rukiye, Ercelep, Ozlem, Ozguven, Salih, Soysal, Sunullah, Memisoglu, Asli, Dane, Faysal, Yumuk, Perran Fulden

“…Background Gastric cancer is rare during pregnancy and often diagnosed at a later stage due to overlapping symptoms of pregnancy. Breast metastasis of gastric…”
Get full text

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study by Benekli, Mustafa, Gumus, Mahmut, Ozkan, Metin, Dane, Faysal, Elkiran, Emin T., Cicin, Irfan, Sevinc, Alper, Aliustaoglu, Mehmet, Isikdogan, Abdurrahman, Meydan, Nezih, Oksuzoglu, Berna, Ozyilkan, Ozgur, Artac, Mehmet, Ozdemir, Feyyaz, Kilickap, Sadettin

“…Objective Cytokines have been the mainstay of treatment in metastatic renal cell cancer (mRCC) for decades before the introduction of tyrosine kinase…”
Get full text

Chordoma: a case series and review of the literature by Alan, Ozkan, Akin Telli, Tugba, Ercelep, Ozlem, Tanrikulu Simsek, Eda, Basoglu Tuylu, Tugba, Mutis, Aydan, Hasanov, Rahib, Kaya, Serap, Akgül Babacan, Nalan, Dane, Faysal, Yumuk, Perran Fulden

“…Chordoma is a rare malignant tumor of the skull base and axial skeleton, with an incidence of less than 0.1/100,000 per year. Patients with advanced chordoma…”
Get full text

Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma by Başoğlu, Tuğba, Akar, Kadriye Ebru, Bağcı, Pelin, Akgül Babacan, Nalan, Öztürk, Mehmet Akif, Öztürk, Fatih Emin, Demircan, Nazım Can, Arikan, Rukiye, Akın Telli, Tuğba, Ercelep, Özlem, Dane, Faysal, Yumuk, Perran Fulden

“…Pancreatic ductal adenocarcinoma differs from other solid tumors with its unique immunosuppressive microenvironment and non-immunogenic feature. There are not…”
Get full text

Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib by Demircan, Nazım C, Alan, Özkan, Başoğlu Tüylü, Tuğba, Akın Telli, Tuğba, Arıkan, Rukiye, Çiçek, Furkan C, Ercelep, Özlem, Öztürk, Mehmet A, Alsan Çetin, İlknur, Ergelen, Rabia, Tinay, İlker, Akgül Babacan, Nalan, Kaya, Serap, Dane, Faysal, Yumuk, Perran F

“…Background Anti-angiogenic tyrosine kinase inhibitors, sunitinib and pazopanib, have proven efficacy in advanced renal cell carcinoma, with specific adverse…”
Get full text

Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA) by Ozaslan, Ersin, Ozkan, Metin, Cicin, Irfan, Benekli, Mustafa, Kocer, Murat, Uysal, Mukremin, Oksuzoglu, Berna, Isikdogan, Abdurrahman, Cubukcu, Erdem, Elkiran, Emin T., Dane, Faysal, Aliustaoglu, Mehmet, Sevinc, Alper, Karaoglu, Aziz, Ulas, Arife, Gokoz-Dogu, Gamze

“…We compared the efficacy and safety of low-molecular-weight heparins (LMWHs) in patients with cancer who are at low risk of venous thromboembolism (VTE)…”
Get full text

Systemic chemotherapy of advanced soft tissue sarcomas by Besiroglu, Mehmet, Dane, Faysal, Ciltas, Aydin, Benekli, Mustafa

“…Soft tissue sarcomas, which originate from the mesenchymal tissue, represent a rare disease group with more than 100 subtypes. Primary treatment is surgical…”
Get full text

Carbon-14 urea breath test: does it work in patients with partial gastric resection? by Dede, Fuat, Civen, Hüseyin, Dane, Faysal, Aliustaoglu, Mehmet, Turhal, Serdar, Turoglu, Halil Turgut, Inanir, Sabahat

“…Objective The diagnostic value of Carbon-14 urea breath test (C-14 UBT) in the detection of Helicobacter pylori (H. pylori) infection in non-operated patients…”
Get full text

The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy by Atasoy, Beste M., Yonal, Oya, Demirel, Birsen, Dane, Faysal, Yilmaz, Yusuf, Kalayci, Cem, Abacioglu, Ufuk, Imeryuz, Nese

“…To investigate the impact of early insertion of percutaneous endoscopic gastrostomy-tube on nutritional status and completeness of concurrent chemotherapy in…”
Get full text

Radiation-induced oxidative injury of the ileum and colon is alleviated by glucagon-like peptide-1 and -2 by Deniz, Mustafa, Atasoy, Beste M., Dane, Faysal, Can, Güray, Erzik, Can, Çetinel, Şule, Yeğen, Berrak Ç.

“…The present study was conducted to characterize the possible therapeutic effects of glucagon-like peptide (GLP)-1 and GLP-2 against oxidative damage in the…”
Get full text

Adequacy of Lymph Node Dissection Should be Taken into Consideration While Determining the Prognostic Significance of the Lymph Node Ratio: In Regard to Kim et al. ( Int J Radiat Oncol Biol Phys 2009;74:796–802) by Dane, Faysal, M.D, Öztürk, Mehmet Akif, M.D, Turhal, Serdar, M.D

Get full text